KCNJ4
MOLECULAR TARGETpotassium inwardly rectifying channel subfamily J member 4
KCNJ4 (potassium inwardly rectifying channel subfamily J member 4) is targeted by 5 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting KCNJ4
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Arachidonic Acid | 0.69 | 1 |
| 2 | Spermidine | 0.69 | 1 |
| 3 | Putrescine | 0.69 | 1 |
| 4 | SCH 23390 [Supplementary Concept] | 0.69 | 1 |
| 5 | Spermine | 0.69 | 1 |
About KCNJ4 as a Drug Target
KCNJ4 (potassium inwardly rectifying channel subfamily J member 4) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 5 compounds with documented KCNJ4 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
KCNJ4 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.